Cargando…

Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

Patients with unresectable metastatic colorectal cancer live for a median of three years when treated with standard therapies. While the evidence guiding cancer-directed treatment of this disease comes from phase III trials that have mostly enrolled patients with good performance status, some patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rocha, Lucila Soares da Silva, Riechelmann, Rachel P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142860/ https://www.ncbi.nlm.nih.gov/pubmed/30281700 http://dx.doi.org/10.6061/clinics/2018/e542s

Ejemplares similares

Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications
por: Shitara, Kohei, et al.
Publicado: (2010)

Complications from carcinoid syndrome: review of the current evidence
por: Mota, José Mauricio, et al.
Publicado: (2016)

Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status
por: Fiorin de Vasconcellos, Vitor, et al.
Publicado: (2019)

Refractory Metastatic Colorectal Cancer: Current Challenges and Future Prospects
por: Lam, Marissa, et al.
Publicado: (2020)

Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
por: Pfeiffer, Per, et al.
Publicado: (2009)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer
por: Kim, Sun Young, et al.
Publicado: (2020)

Unresectable metastatic colorectal cancer in fit patients – a practical algorithm of treatment sequencing from the Brazilian Group of Gastrointestinal Tumours (GTG)
por: Peixoto, Renata D’Alpino, et al.
Publicado: (2023)

Significance of poor performance status after resection of colorectal liver metastases
por: Strandberg Holka, Peter, et al.
Publicado: (2018)

Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

The Challenge of Metastatic Colorectal Cancer
por: Cidón, Esther Uña
Publicado: (2010)

Immunotherapy in microsatellite instability metastatic colorectal cancer: Current status and future perspectives
por: Motta, Rodrigo, et al.
Publicado: (2021)

Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments
por: Tang, Yuan-Ling, et al.
Publicado: (2023)

Recruiting Immunity for the Fight against Colorectal Cancer: Current Status and Challenges
por: Al-Hujaily, Ensaf M., et al.
Publicado: (2022)

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
por: de Jesus, Victor Hugo Fonseca, et al.
Publicado: (2023)

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer
por: Berardi, Rossana, et al.
Publicado: (2010)

Current status of surgical treatment of colorectal liver metastases
por: Xu, Feng, et al.
Publicado: (2018)

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023)

Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013)

Colorectal Stents: Current Status
por: Lee, Jeong-Mi, et al.
Publicado: (2015)

First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
por: Webb, Mason J., et al.
Publicado: (2023)

Current Targeted Therapy for Metastatic Colorectal Cancer
por: Ohishi, Tomokazu, et al.
Publicado: (2023)

Korean Medicine in General Practice: Current Status, Challenges, and Vision in Clinical Evidence
por: Kim, Tae-Hun, et al.
Publicado: (2016)

Treatment of metastatic colorectal cancer: focus on panitumumab
por: Tay, Rebecca Y, et al.
Publicado: (2015)

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
por: Garajová, Ingrid, et al.
Publicado: (2017)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
por: Jung, Gerhard, et al.
Publicado: (2020)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Current status and perspectives in immunotherapy for metastatic melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2018)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Challenges and Current Status of the Biological Treatment of PFAS-Contaminated Soils
por: Shahsavari, Esmaeil, et al.
Publicado: (2021)

Current Status and Challenges of Stem Cell Treatment for Alzheimer’s Disease
por: Pacheco-Herrero, Mar, et al.
Publicado: (2021)

Surgical treatment for recurrent hepatocellular carcinoma: Current status and challenges
por: Wang, Di, et al.
Publicado: (2023)

Recurrence-free survival as a putative surrogate for overall survival in phase III trials of curative-intent treatment of colorectal liver metastases: Systematic review
por: Araujo, Raphael L C, et al.
Publicado: (2017)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

Current status of and future prospects for the treatment of unresectable or metastatic gastrointestinal stromal tumours
por: Naito, Yoichi, et al.
Publicado: (2023)

CCR5 status and metastatic progression in colorectal cancer
por: Suarez-Carmona, Meggy, et al.
Publicado: (2019)

The current status of treatment for colorectal cancer in China: A systematic review
por: Zhang, Yumei, et al.
Publicado: (2017)

EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer
por: Venderbosch, Sabine, et al.
Publicado: (2015)

Fibrosis in metastatic lymph nodes is clinically correlated to poor prognosis in colorectal cancer
por: Ikuta, Daiji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_irghfjb71c70p9he84ni55a989